Related references
Note: Only part of the references are listed.Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19
Sarah C. J. Jorgensen et al.
PHARMACOTHERAPY (2020)
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
Francois Montastruc et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Meagan L. Adamsick et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
AKI in Hospitalized Patients with and without COVID-19: A Comparison Study
Molly Fisher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Safety profile of the antiviral drug remdesivir: An update
Qianqian Fan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori et al.
PHARMACOLOGICAL RESEARCH (2020)
Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment
James Fung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cyclodextrin (SBECD)
David R. Luke et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
Antiviral drug-induced nephrotoxicity
H Izzedine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Use of measures of disproportionality in pharmacovigilance - Three Dutch examples
ACG Egberts et al.
DRUG SAFETY (2002)
Share Paper
